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Summary
Objective: To compare the performance of visual analogue (VAS) vs categorical (CT) scaled versions of the three subscales (pain, stiffness
and difficulty) of the WOMAC Index in patients with knee osteoarthritis.
Material and methods: Patients with knee OA (at least grade II of Kellgren & Lawrence classification) were treated for a 6-weeks period with
an NSAID. The following measures were applied at baseline and after treatment: VAS and CT WOMAC scales, Lequesne Index, pain on
VAS, and global assessment by patient and observer. Construct Validity was determined by correlation of each of the subscale scores with
the other outcomes both at baseline and after treatment (Pearson’s test); responsiveness comparing baseline vs final status by Wilcoxon’s
test; reliability by analysis of the internal consistency using Cronbach’s alpha at baseline and after the treatment period; and test–retest
reliability by Kendall’s Tau-c statistics. Finally, correlation and analysis of the relative efficiency (RE) between the subscales of both formats
were tested.
Results: Seventy-three (8 men and 65 women) patients with a mean disease duration from first diagnosis of 69 months (3 to 254) completed
the study. The following were the observed values for the instruments’ psychometric properties: (1) construct validity: correlations ranged
from 0.30 to 0.84 for VAS and 0.27 to 0.77 for CT subscales; (2) responsiveness: achieved P values for the pain, stiffness and difficulty scales
were P<0.0001, P=0.002 and P<0.0001 in VAS and P=0.003, P<0.0001 and P=0.001 in CT format respectively; (3) internal consistency: the
obtained Cronbach’s alpha coefficients ranged from 0.71 to 0.97 for the VAS and 0.64 to 0.95 for the CT subscales; (4) test–retest reliability:
correlation coefficients ranged from 0.36 to 0.76 for VAS and 0.34 to 0.52 for CT subscales; and (5) the relative efficiency of the subscales
in VAS vs CT format were 2.20, 0.91 and 1.91 for pain, stiffness and difficulty respectively. Significant correlations between subscales in both
formats ranging from 0.72 to 0.86 were observed.
Conclusion: We have shown that both the VAS version of WOMAC have adequate evaluative and discriminative properties. We found the
pain and physical function scales in VAS format and the stiffness scale in CT format to have a slightly better performance in this sample.
© 2003 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Introduction
The Western Ontario and McMaster Universities Osteo-
arthritis Index (WOMAC) is a disease and joint specific
instrument, developed for the evaluation of knee and/or hip
osteoarthritis (OA). Since its initial validation it has been
widely used and has become the measure of choice for the
assessment of OA patients both in clinical trials and obser-
vational studies. The questionnaire includes three sub-
scales that target three of the most relevant outcomes in
OA1: specifically, the dimension of pain (5 items), stiffness
(2 items) and physical function (17 items).
The use of standard and validated instruments that have
been subject of a sound process of transcultural adaptation
and revalidation is critical when the researchers’ goal is to
perform international – even inter-regional – comparative
analyses of disease outcomes, to carry out analytic sys-
tematic reviews, or to conduct multinational clinical
trials2–4. Moreover, when performing outcomes evaluation,
especially in the setting of clinical trials, the use of instru-
ments with the highest established levels of reliability and
discriminative power becomes crucial. Otherwise the stat-
istical estimates that are obtained constitute highly attenu-
ated versions of the true population parameters, which
could have a great impact on the required sample size and,
hence, on the budget required for the study. It is suggested
that, when giving their answers to the formulated questions,
some individuals find it difficult to place their responses on
visual analogue scales (VAS) and prefer to do so on
categorical (CT) scaled questionnaires5,6. This could fur-
ther increase measurement error and have an additional
impact on the reliability of that measurement. The WOMAC
Index is available in both VAS and CT formats, but, to our
best knowledge, only one comparative evaluation of both
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formats of the questionnaire has been published, which
was performed in the context of the original validation of the
instrument7–9. More recently, the development and vali-
dation of a computerized version of the Index has been
reported10. We have reported elsewhere the transcultural
adaptation and re validation of Spanish visual analogue
and categorical scaled versions of the WOMAC Index11.
The objective of the present study was to comparatively
evaluate the performance of visual analogue vs categorical
scaled versions of the three WOMAC Index subscales
(pain, stiffness and difficulty) in a sample of patients with
knee osteoarthritis that participated in a NSAID clinical trial
in Spain.
Subjects and methods
Patients with symptomatic OA of the knee, as defined by
the American College of Rheumatology (ACR) criteria12,
were screened and recruited to participate in a multi-center,
double-blind, randomized, clinical trial for the comparison
of two formulations of the same nonsteroidal anti-
inflammatory drug (NSAIDs). Consecutive patients attend-
ing the participating rheumatology clinics from November
1997 to December 1998 were screened to participate in the
study. Patients were recruited after obtaining informed
consent and verifying the inclusion and exclusion criteria
(as defined per clinical trial protocol). Approval from the
corresponding institution’s review board was obtained.
Data of subjects recruited in two of the centers was used
for the present analysis, which was conducted at the
Department of Rheumatology, Virgen Macarena University
Hospital, Seville, Spain.
Inclusion criteria were: age of 35–75 years; a disease
duration (from diagnosis of knee OA) of at least one year;
knee pain on most days in the last month, with a score of at
least 40 mm on a 0 to 100 mm VAS; persistent knee pain
after a 2-week NSAID wash-out period; a score of 4 to 14
(both inclusive) on the Lequesne Index (see description
below); and definite radiographic evidence of primary knee
OA, defined as at least grade 2 (Kellgren & Lawrence
classification13) on an X-ray performed in the previous 6
months. Potential participants were excluded if they had:
inflammatory arthritis (e.g., rheumatoid arthritis, psoriatic
arthritis) any comorbidity that precluded safe use of
NSAIDs; and, any condition that interfered with outcomes
evaluation.
Assessments were performed at the outpatients’ clinics
in each center. Data for this study corresponded to the
baseline and post-treatment (6 weeks) evaluations. Data
was collected in an interview format using the below
described self-reported measures and instruments.
MEASUREMENTS
The Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC)7–9. This is a validated, 24-
item, disease and joint-specific measure that evaluates
knee pain, stiffness and physical function. The instrument
has been designed as a self-report measure. The time
frame for evaluation selected for this study was the
previous 72 h. As said, the instrument contains three
subscales:
1 The physical function (difficulty) subscale comprises 17
items. Participants are asked to rate the intensity of
their difficulty to perform a wide range of activities, such
as ascending or descending stairs, walking, bending or
performing daily activities, on a 0 to 100 horizontal
scale anchored with the Spanish words corresponding
to ‘No difficulty’ and ‘Very intense difficulty’ on the left
and right extremes respectively. Bellamy et al. showed
the adequate validity (correlation coefficients ranging
from 0.36 to 0.59) excellent internal consistency
(Cronbach’s alpha 0.91) and test–retest reliability
(Kendall Tau-c coefficient=0.72) of this scale9.
2 The pain subscale comprises five items. Patients were
asked about the intensity of pain in the reference knee.
Activity pain, night pain and pain at rest were assessed
with the five items that constitute this subscale. A 0 to
100 VAS format was used, as described for the physi-
cal function subscale, for each of the items; in this case
anchored with the Spanish words corresponding to ‘No
pain’ and ‘Very intense pain’. This scale has also shown
adequate validity (correlation coefficients ranging from
0.40 to 0.62), high internal consistency (Cronbach’s
alpha 0.81) and test–retest reliability (Kendall Tau-c
coefficient=0.68)9.
3 The stiffness subscale of the WOMAC Index comprises
two items. Participants were asked about the intensity
of the stiffness in two different situations: during the
morning, right after waking up, and during the day after
some period of rest or inactivity. The 0 to 100 VAS was
anchored with the Spanish words corresponding to ‘No
stiffness’ and ‘Very intense stiffness’. This scale has
shown adequate validity (correlation coefficients rang-
ing from 0.32 to 0.46) excellent internal consistency
(Cronbach’s alpha 0.90) and test–retest reliability
(Kendall Tau-c coefficient=0.61)9.
The WOMAC Index was also applied in five-point
categorical-answer format to meet the objective of the
comparative performance of both formats. The adjectives
located at the extreme of the categorical scales were the
same that were used to anchor the above-described VA
scales, plus the adjectives ‘mild’, ‘moderate’, and ‘intense’
were added to label the five categories.
Lequesne algo-functional Index14,15
This index has been used extensively in European OA
studies since 1980. The index includes three sections with
a total of ten questions and takes a few minutes to
complete. The first section asks about pain or discomfort
‘At night’, ‘After getting up in the morning’, ‘When standing’,
‘When walking’ and ‘When rising from sitting’ (knee index)
and pain when ‘Sitting two hours’ (hip index). The items are
graded with dichotomous or categorical answers. The
second section asks about the maximum walking distance.
If patients use one or two walking aids (canes, crutches. . .)
the score is raised by one or two points, respectively. The
third section addresses physical function disability with five
categories, graded from 0= ‘without difficulty’ to 2=‘unable
to do’. The Lequesne OA-index is scored as the sum of all
questions. The score range of each section is from 0 to 8
resulting in a total score ranging from 0 to 24. The
Lequesne OA-index waseen developed using an interview
format.
Global knee pain on a 0 to 100 VAS, answering to the
question: How much pain have you had in your knee during
the past week? Participants were instructed to chose a
reference knee. The scale was anchored with the words
‘No pain’ and ‘Most severe pain possible’ at the left and
right extreme, respectively. This type of scale has shown
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high levels of reliability (coefficients ∼0.90)16 and validity
(correlation coefficients with other scales measuring pain
ranging from 0.71 to 0.91)17.
Patient and physician’s global assessment of
disease activity
Participants were asked to rate the activity of the arthritis
on the reference knee in the previous week on a 0 to 100
VAS anchored with ‘No activity’ and ‘Very severe activity’.
Physicians were required to complete this assessment
after physical examination and blinded from the results of
patient’s evaluations.
Patient’s perceived level of improvement
At the 6-week evaluation, patients were asked to report
their perceived level of improvement on a seven-point
Likert-type scale that included the following adjectives:
much worse, worse, somewhat worse, the same, some-
what better, better, much better. This scale was used to
identify patients that remained clinically stable after the six
weeks of treatment.
CROSS-CULTURAL ADAPTATION
The two versions of the index (VAS and CT formats)
were adapted following standard guidelines for cross-
cultural adaptation of health-related quality of life
measures3. The results of this adaptation has been
reported elsewhere11. In brief, three bilingual persons (two
Spanish investigators and a native English speaking
teacher) performed a translation of the original instrument.
The three versions were reviewed and, due to the similarity
of all of them, it was decided to obtain only one back
translation to be performed by the teacher, who was
unaware of the intent of the original instrument. Then, a
committee composed of three investigators (rheumatolo-
gists) and a research nurse reviewed the source and the
final versions. The task of the committee was to identify
potential discrepancies and problems with specific items
and solve them to ensure that the final version maintained
content validity and conceptual equivalency. Few items
were modified during this process. In general, it was
perceived that, due to the characteristics of the original
instrument, the process of adaptation was straightforward;
source and final versions were considered to be equivalent.
Only one item corresponding to the difficulty subscale was
problematic: ‘Bending to floor’. The discrepancy was
resolved after consulting with a native English speaking
person. Finally, the final instrument was pre-tested on a
sample of 10 OA patients. Subjects were asked if they
found any difficulty understanding the instructions and the
items included in the questionnaire. None of them
expressed any difficulty understanding what they were
asked in any of the items. The only source of difficulty that
we found was related with the format of the answer itself.
Some subjects showed initial problems in understanding
the process of answering on a VAS, but that difficulty was
overcome after a short training with example questions.
The interviewer exemplified marking on the scale the
potential responses in the hypothetical questions/scenarios
were the patient would have ‘no pain at all’, ‘average/
moderate pain’ and ‘pain very intense’. For example, the
interviewer showed to the patients where they would put
their marks on the VAS if they did not have any pain (just on
the left anchor in this case).
ANALYSIS
Following standard guidelines for the evaluation of
measurement properties of quality of life instruments18, we
comparatively tested the validity, reliability and responsive-
ness of both Spanish versions (VA and CT) of the WOMAC
Index. The feasibility of each instrument was also evalu-
ated as a measure of their potential applicability in the
Spanish population. This was carried out by assessing the
number of subjects that completed the questionnaire;
their level of comprehension of the instruments’ content on
a five-point categorical scale; and the required time for
completion of the instrument.
Validity
We examined construct validity (convergent and
divergent – or discriminant) by correlating the scores of the
index subscales with the other measures applied in the
study (see measurements). A particular subscale is ex-
pected to converge with the scores of those instruments
targeting the same construct, and to deviate from the
scores given by instruments or scales assessing a different
one. To quantify these relationships, Pearson’s correlation
coefficients were obtained.
Reliability
It was examined in two different ways. First, we assessed
the internal consistency, which gives a measure of the
stability across the items that constitute a particular scale
and with the total score of the scale. Internal consistency
was tested using Cronbach’s alpha coefficients, which were
obtained at baseline and post-treatment. Second, we
examined the test–retest reliability, which examines the
stability of the measurements across evaluations with the
same scale performed at different time points. To test this
property, Intraclass Correlation Coefficients were obtained
for those patients with unchanged clinical status after
treatment, as perceived by the patient.
Responsiveness
We tested the sensitivity to change of both versions of
the index by assessing the ability of their corresponding
subscales to detect within-subject changes. This was
achieved by comparing the scores at baseline and 6-weeks
(post-treatment) using a Wilcoxon’s Rank test. The respon-
siveness of both versions of the instrument was determined
by computing their relative efficiency, This estimtes the
extent to which one scale is more or less efficient at
detecting change over time relative to another scale. Rela-
tive efficiency and the significance of change scores are
typically computed from paired-samples t-tests as pairwise
squared t-values (t2 scale l/t2 scale 2).19 However, results
generated by this method confound ‘responsiveness’ with
the effects of nonnormality such that scales with more
normally distributed outcomes are favored. Therefore, we
examined the significance of chance scores using Wilcox-
on’s matched-pairs signed-ranks test and computed rela-
tive efficiency as pairwise squared z-values z2 scale l/z2
scale 2) generated by this test20. The z-value for the
WOMAC scales in VAS format were chosen as the denomi-
nators so that values for the WOMAC scales in CT format
estimate their relative efficiency as a percentage of the VAS
scales.
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Results
Data from 73 (eight men and 65 women) subjects with a
confirmed diagnosis of knee OA, and meeting the trial’s
inclusion and exclusion criteria, were used for this analysis.
The average disease duration from OA diagnosis was 74
months (range 3 to 264) and the mean patients’ age was
57.3 years (range 35 to 73). Patients’ characteristics at
baseline are shown in Table I.
FEASIBILITY
The average time for completion of the three subscales
of the WOMAC Index was 7.24 and 7.48 minutes for the
VAS and CT formats respectively. All participants com-
pleted the instruments both at baseline and 6-weeks evalu-
ations. To examine participants’ level of comprehension of
the instruments’ content, a proxy question was asked; did
you have any difficulty understanding the questionnaire
items? (To be answered on a five-point CT scale). Sixty-
one participants affirmed they had ‘no difficulty’, ten partici-
pants found ‘some difficulty’ and only two respondents
seemed to have ‘moderate difficulty’ in understanding and
responding to the items.
DISCRIMINATIVE PROPERTIES
Validity
Construct validity. As hypothesized, several positive and
highly significant correlation coefficients (Pearson’s test)
between the subscales corresponding to both the VAS and
CT versions of the WOMAC Index and Lequesne sub-
scales, global pain on 0 to 100 VAS, and Global assess-
ments by the patient and the physician, were obtained.
Correlation coefficients ranged from 0.30 to 0.84 for the
VAS subscales and 0.27 to 0.77 for the CT versions. All
subscales showed a good level of convergence with other
measures testing the same dimension or construct, as
demonstrated by the observed highly significant correla-
tions. Table II shows the coefficients for the VAS and CT
versions, respectively. Both versions also showed a suf-
ficient level of discriminant validity (divergent construct
validity), as demonstrated by the fact that the correlation
coefficients were higher with measures testing the same
dimension than with measures testing a different construct
(Table II). Similar coefficients were obtained for both the
VAS and CT versions, indicating very similar levels of
construct validity.
Finally, high correlation coefficients were obtained be-
tween VAS and CT pain, stiffness and physical function
subscales both at baseline (Table III: the nine values in the
left upper section) and final evaluation (Table III: the nine
values in the right lower section). In general, the coef-
ficients were higher between subscales measuring the
same construct and lower between those targeting a differ-
ent dimension. The coefficients were in general higher for
the final evaluation, which probably indicates a decrease in
measurement error as a result of a learning effect from the
baseline assessment. These results further support the
convergence and discriminative ability of the subscales in
both formats, and indicate a high level of agreement
between both Spanish versions of the WOMAC Index.
Criterion validity. We also tested the discriminative proper-
ties of the two versions of the WOMAC Index by contrasting
their respective total score with the dichotomized patient’s
global evaluation, which was measured on a 0 to 100 VAS;
the dichotomization was based on the observed median
score, which split the sample in two groups: subjects with
worse vs better perceived disease status. To examine the
ability of the instruments to discriminate subjects in each
group, ROC curves plotting the sensitivity vs 1-specificity
were obtained. The observed areas under the curve were
0.75 (95% CI, 0.64–0.86) and 0.68 (95% CI, 0.55–0.80) for
the VAS and CT versions, respectively, indicating only
slightly better discriminative ability for the VAS format
(Fig. 1).
Reliability
Internal consistency. The Cronbach’s alpha coefficients
obtained both at baseline and final evaluations for the
scales in VAS and CT format are shown in Table IV. In
general the coefficients were slightly higher for the VAS
subscales and better in the second evaluation, which again
probably indicates a decrease in measurement error as a
consequence of some learning after the first evaluation.
The obtained coefficients for the post-treatment evaluation
Table I
Characteristics of participants at baseline
n=73
Age (mean-range) 58.71 (35–73)
Sex (male/female) 8/65
Mean osteoarthritis duration
(months from diagnosis)
77.62 (3–264)
Educational level (n, %)
Some primary school 62(84.9%)
Complete primary school 7(9.6%)
High school 3(4.1%)
College 1(1.4%)
VAS – WOMAC subscales*
Pain – VA (0 to 50) 26.821(7.65)
Stiffness – VA (0 to 20) 11.74(4.02)
Physical function – VA. (0 to 170) 86.87(28.03)
CT – WOMAC subscales*
Pain – CT (0 to 20) 10.38(3.51)
Stiffness – CT (0 to 8) 4.93(1.69)
Physical function – CT (0 to 68) 34.16(11.51)
Lequesne Index scores*
Pain (0 to 8) 5.01(0.89)
Physical function (distance+activities)
(0 to 16)
5.47(1.65)
Total score (0 to 24) 10.47(2.06)
Pain on VAS (0 to 100) 66.68(20.81)
Global evaluation by the patient
on VAS (0 to 100)*
68.01(15.39)
Global evaluation by the observer
on VAS (0 to 100)*
58.67(14.18)
Radiological classification, n (%)
(Kellgren & Lawrence)
Grade II 14(19.40)
Grade III 45(61.20)
Grade IV 14(19.40)
*Mean (S.D.)
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were excellent for both versions of the Index with some-
what smaller values for the stiffness subscale, which was
expected for a scale with only two items.
Test–retest reliability. It was evaluated only in the 17
patients that reported remaining clinically stable during the
study period (answered they were ‘the same’ on the cited
seven-point Likert-type scale). The obtained Intraclass
Correlation Coefficients between the baseline and post-
treatment evaluations for both the scales in VAS and CT
format are shown in Table IV. Despite the strategy used to
determine test–retest reliability and the time difference
between both evaluations, the obtained coefficients were
more than acceptable. Again, the coefficients were smaller
for the stiffness subscale in both the VAS and CT versions,
probably due to the fact that they are composed only by two
items. Test–retest reliability was also tested in those same
patients by comparison of the baseline and post-treatment
evaluations using a Wilcoxon’s Rank test. As desired, the
comparisons for each subscale yielded a non-significant
result (P values ranging from 0.12 to 0.88 for the VAS
version, and 0.12 to 0.85 for the CT version).
Evaluative properties
Responsiveness. The ability to detect change of the scales
was evaluated by means of the comparison of the baseline
and post-treatment evaluations, using Wilcoxon’s Rank
tests. The results of these comparisons are shown in
Table V. A highly statistically significant improvement was
observed for all WOMAC subscales both in VAS and CT
format after the treatment period. Based on the obtained P
values, the pain and physical function subscales of the
WOMAC Index in CT format were slightly less sensitive to
change than the VAS version, but the stiffness subscale
was slightly more sensitive in CT format. The scales of
Global Knee pain, Global assessments by the patient and
the physician, Lequesne Pain and Lequesne Physical
Function also improved significantly (data not shown).
Relative efficiency statistics showed that the pain and
physical function scales in CT format were estimated to be
48% and 52% as efficient at detecting change as the same
scales in VAS format in this sample (relative efficiency
coefficients: 0.48 and 0.52, respectively). However, the
stiffness scale in CT format proved to be 21% more efficient
than the scale in VAS format at detecting change (relative
efficiency coefficients: 1.21).
Discusion
The results of this study suggest that both the VAS and
CT Spanish versions of the WOMAC have adequate evalu-
ative and discriminative properties. We have shown both
versions of the Index to be feasible, to have excellent levels
of reliability and validity, and to be highly responsive to
within-subject changes over time. These results were very
similar to those reported in the original validations of the
English versions of the WOMAC Index7,8. Similar to
Bellamy et al.7,8, the evaluations were performed in the
context of a clinical trial. Although the evaluation context
could differ in other types of studies, there is no reason to
believe that the instruments would show worse perform-
ance in the setting of observational studies or even in the
routine clinical practice9. The observed measurement prop-
erties clearly support their use in the evaluation of pain,
stiffness, and physical function levels in patients with knee
OA, which were to be recruited from the general Spanish
population.
Table II
Correlation coefficients for the WOMAC–VAS/CT scales and other measures (Pearson’s Test)
WOMAC scales Lequesne pain Lequesne function Lequesne stiffness Global pain (VAS) PGA
(VAS)
OGA
(VAS)
Pain – VAS 0.38* 0.53** 0.38* 0.63** 0.42** 0.62**
Stiffness – VAS 0.08 0.38* 0.70** 0.43** 0.37* 0.56**
Physical function – VAS 0.33† 0.72** 0.61** 0.68** 0.43** 0.78**
Pain – CT 0.31† 0.52** 0.57** 0.53** 0.33‡ 0.64**
Stiffness – CT 0.17 0.46** 0.71** 0.49** 0.31‡ 0.57**
Physical function – CT 0.24† 0.66** 0.58** 0.62** 0.37* 0.70**
*P=0.001.
**P<0.001.
†P<0.05.
‡P<0.05.
VAS=visual analogue scale; CT=categorical; PGA=patient global assessment; OGA=observer global assessment.
Table III
Correlation coefficients for the WOMAC–VAS and CT scales at both baseline and final evaluations (Pearson’s Test)
Pain
VAS (b)*
Stiffness
VAS (b) *
Physical function
VAS (b) *
Pain
VAS (f)†
Stiffness
VAS (f) †
Physical function
VAS (f) †
Pain – CT (b) * 0.72 0.39 0.83
Stiffness – CT (b) * 0.70 0.75 0.82
Physical – CT (b) * 0.68 0.55 0.86
Pain – CT (f) † 0.57 0.70 0.68
Stiffness – CT (f) 0.74 0.81 0.75
Physical – CT (f) † 0.71 0.75 0.86
*(b)=Baseline evaluation.
†(f)=Evaluation after 6 weeks of treatment. VAS=visual analogue scale; CT=categorical.
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Although both versions of the questionnaire showed
good performance, similar measurement properties and a
fairly good level of agreement – as reported by the re-
searchers that developed the Index9, we found the VAS
version of the WOMAC Index to have slightly higher levels
of convergent and discriminant validity, internal consist-
ency, test–retest reliability and responsiveness. However,
the stiffness subscale in CT format proved to be more
reliable, as evidenced by its slightly higher levels of both
internal consistency and test–retest reliability, than the
corresponding VAS version. The relative efficiency was, in
general, higher for the scales in VAS format as compared to
those in CT format.
These results are consistent with what was reported in
the original validation study, where the VAS version of the
Index was found to be more sensitive to changes7. Those
authors suggested in their report that the selection of one or
the other version of the Index could depend on researchers’
preferences. From our results we would recommend the
use of the VAS version, but we recognize that the CT
version of the Index is a good alternative in the case that
either the researcher or the patient should prefer this
format. We think that the CT version would benefit from
changing the number of possible response categories from
5 to 7; this would probably enhance its measurement
properties, particularly its sensitivity to change, but it would
require a new validation study to confirm this possibility. We
recognize that some of the observed differences between
VAS and CT versions could reside in the intrinsic charac-
teristics of the computation of scores and the resulting
frequency distributions for the obtained values. To explore
this potential source of error we performed the analyses
with both parametric and non-parametric tests, which
essentially gave the same results.
The three subscales of the Index showed similar
measurement properties – both in VAS and CT format but
the stiffness subscale seemed to have worse performance.
This could reside in the fact that this particular scale is the
shorter (i.e., only composed of two items). However we
found the stiffness subscale to be more reliable in CT
format, which could be due, at least in part, to the recog-
nized difficulty that patients have in expressing their level of
perceived stiffness10. In this case, patients probably found
it easier to score their stiffness on a scale with concrete
descriptions of the intensity level of stiffness.
Table IV
Reliability coefficients: Internal consistency (Cronbach’s AA) and
Test-retest (Intraclass correlation coefficient)
Internal consistency
WOMAC scales Baseline Final Test–retest
Pain – VAS 0.71 0.91 0.71
Stiffness – VAS 0.74 0.81 0.50
Physical function – VAS 0.94 0.97 0.83
Pain – CT 0.77 0.79 0.55
Stiffness – CT 0.64 0.76 0.62
Physical function – CT 0.93 0.95 0.77
Table V
Responsiveness of the WOMAC subscales (Wilcoxon’s Rank
Test)*
Baseline Final P
Pain – VAS 26.82 (7.65) 20.82 (10.82) <0.0001
Stiffness – VAS 11.74 (4.02) 8.63 (5.17) 0.002
Difficulty – VAS 97.38 (28.02) 78.25 (34.01) <0.0001
Pain – CT 10.38 (3.51) 8.60 (3.48) 0.003
Stiffness – CT 4.93 (1.69) 3.81 (1.92) <0.0001
Difficulty – CT 38.9 (11.50) 33.05 (12.57) 0.001
*Results are expressed in mean (S.D.).
VAS=visual analogue scale; CT=categorical.
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Fig. 1. ROC curves for criterion validity test.
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Some investigators have reported that patients find it
difficult to respond to VAS scaled questionnaires, especially
illiterate patients5,6. We have found that not to be the
case in our sample, which was composed of subjects with
low educational level. Our results suggest that subjects
exposed to a single previous application of the instrument
increase their confidence with the measurement in VAS
format, as shown by the higher internal consistency levels
observed in the final evaluation. The evaluations were in an
interview format, which could have some influence on the
ability of subjects to respond on VAS. The developers of the
WOMAC Index found the same in their research10.
In conclusion, we have shown that both the VAS and CT
Spanish versions of the WOMAC have adequate evaluative
and discriminative properties. We found the pain and
physical function scales in VAS format and the stiffness
scale in CT format to have slightly better performance in
this sample, which could have some impact on the required
sample size to detect meaningful differences.
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